Gemcitabine (Gemzar) and irinotecan (CPT-11, Camptosar) are active cytotoxic drugs against pancreatic cancer. Preclinical data evaluating the combination of gemcitabine and irinotecan suggest dose-dependent synergistic
Chris Y. Brunson, MD
Advertisement
Articles by Chris Y. Brunson, MD
Advertisement
Latest Updated Articles
- Irinotecan/Gemcitabine Combination Chemotherapy in Pancreatic Cancer
Published: March 2nd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Immune Priming Strategies Numerically Improve PFS in Ovarian Cancer
2
Non-Viral Gene Therapy Displays Feasibility in EGFR-Mutated NSCLC
3
Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology
4
Who Should Undergo Hereditary Genetic Testing for Cancer?
5
